Paula Soteropoulos

Paula Soteropoulos

Direttore/Membro del Consiglio presso UNIQURE N.V.

Patrimonio netto: 101 713 $ in data 30/04/2024

56 anni
Health Technology
Commercial Services
Consumer Services

Provenienza dei contatti di primo grado di Paula Soteropoulos

EntitàTipo di entitàSettore Industriale
202
Subsidiary Medical Specialties 202
Public Company Biotechnology 45
40
Private Company Investment Managers 40
Subsidiary Pharmaceuticals: Major 23
Public Company Biotechnology 23
Public Company Biotechnology 22
Public Company Biotechnology 9
6
Subsidiary Miscellaneous Commercial Services 6
6
Holding Company Miscellaneous Commercial Services 6
4
Subsidiary Biotechnology 4
Kyowa Kirin, Inc.
1
Private Company 1

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Paula Soteropoulos tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
PFIZER, INC. Pharmaceuticals: Major

Christopher Viehbacher

Martin MacKay

Helen Boudreau

Jennifer Ruff

Chairman

Chief Tech/Sci/R&D Officer

Director of Finance/CFO

Investor Relations Contact

REPLIGEN CORPORATION Pharmaceuticals: Major

Sandy Smith

Jonathan Lieber

Chief Executive Officer

Director of Finance/CFO

ABEONA THERAPEUTICS INC. Pharmaceuticals: Major

Edward Carr

Scott Nogi

Kristina Maximenko

Director of Finance/CFO

Corporate Officer/Principal

Human Resources Officer

ARIAD PHARMACEUTICALS, INC. Biotechnology

Edward Fitzgerald

Sandy Smith

Maria E. Cantor

Director of Finance/CFO

Director/Board Member

Public Communications Contact

IONIS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Sarah Boyce

Christopher F. O. Gabrieli

B. Parshall

Damien McDevitt

Corporate Officer/Principal

Director/Board Member

Director/Board Member

Corporate Officer/Principal

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Sarah Boyce

Stephen Uden

Martin MacKay

Jeremy Springhorn

Michael V. Greco

Jeffrey Fryer

Jacques Suzanne

Sankalp Gokhale

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

General Counsel

Comptroller/Controller/Auditor

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

BIOMARIN PHARMACEUTICAL INC. Biotechnology

Leonard Post

Simrat Randhawa

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

RADIUS HEALTH, INC. Biotechnology

Robert Gut

Judson Taylor

Sankalp Gokhale

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Henri A. Termeer

Lonnie Moulder

David Meeker

Jeremy Springhorn

Director/Board Member

Director/Board Member

Director/Board Member

Corporate Officer/Principal

AURA BIOSCIENCES, INC. Biotechnology

Henri A. Termeer

Alison Lawton

Director/Board Member

Chief Operating Officer

NOVARTIS AG Pharmaceuticals: Major

Sarah Boyce

Mason W. Freeman

Liu Hui

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

University of Virginia College/University

Anne McGeorge

Michael Halpin

Jeannette Potts

Graduate Degree

Graduate Degree

Doctorate Degree

Miscellaneous Commercial Services

Lei Meng

Helen Boudreau

Lucian Iancovici

Gloria Wu

Corporate Officer/Principal

Corporate Officer/Principal

Private Equity Analyst

Consultant / Advisor

The Trustees of Columbia University in The City of New York College/University

Elaine Hochberg

Deborah Palestrant

Simrat Randhawa

Jeffrey Stavenhagen

Masters Business Admin

Doctorate Degree

Masters Business Admin

Doctorate Degree

College/University

Christopher F. O. Gabrieli

Mason W. Freeman

Lei Meng

Kush Parmar

Undergraduate Degree

Undergraduate Degree

Graduate Degree

Doctorate Degree

Stanford University College/University

John Diekman

David Schaffer

Ricardo Dolmetsch

Doctorate Degree

Undergraduate Degree

Doctorate Degree

University of Pennsylvania College/University

Jamil M. Beg

Robert Dolski

Anna Yaeger

Joe Loscalzo

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Graduate Degree

Pharmaceuticals: Major

Leonard Post

Alison Lawton

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Miscellaneous Commercial Services

Edward Fitzgerald

Michael MacLean

Anne McGeorge

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Medical/Nursing Services

Timothy Shannon

Martin MacKay

Robert Hopfner

Kush Parmar

Ron Hunt

Director/Board Member

Chief Executive Officer

Director/Board Member

Director/Board Member

Director/Board Member

501 ACQU Financial Conglomerates

Andrew Schwab

Martin MacKay

Rebecca Lucia

Kush Parmar

Galya Blachman

Chief Executive Officer

Director/Board Member

Director of Finance/CFO

Chief Executive Officer

General Counsel

Harvard Medical School College/University

Henri A. Termeer

Mason W. Freeman

Kush Parmar

Tomas Kiselak

Arthur Tzianabos

Corporate Officer/Principal

Corporate Officer/Principal

Doctorate Degree

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Richard A. Moscicki

Henri A. Termeer

Christopher Viehbacher

David Meek

Chief Tech/Sci/R&D Officer

Director/Board Member

Chairman

Director/Board Member

Boston College College/University

Richard F. Syron

Michael MacLean

Arthur Tzianabos

Jessica Alfano

Director/Board Member

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

The Wharton School of the University of Pennsylvania College/University

Ron Hunt

Robert Dolski

Ron Hunt

Masters Business Admin

Masters Business Admin

Masters Business Admin

Investment Managers

Philip Astley-Sparke

Sander J. van Deventer

Carlo Incerti

Private Equity Investor

Private Equity Investor

Private Equity Investor

Massachusetts Institute of Technology College/University

Henri A. Termeer

Kush Parmar

David Schaffer

Director/Board Member

Doctorate Degree

Doctorate Degree

Investment Managers

John Diekman

Andrew Schwab

Robert Hopfner

Founder

Corporate Officer/Principal

Private Equity Investor

Biotechnology

John Diekman

Andrew Schwab

Kush Parmar

Director/Board Member

Director/Board Member

Director/Board Member

IDEAYA BIOSCIENCES, INC. Pharmaceuticals: Major

Timothy Shannon

John Diekman

Paul Stone

Chairman

Chairman

Director of Finance/CFO

The Leonard N Stern School of Business College/University

Scott Nogi

Jonathan Lieber

Matt Kapusta

Masters Business Admin

Masters Business Admin

Masters Business Admin

Pharmaceuticals: Major

Richard A. Moscicki

Sandy Smith

Carlo Incerti

Chief Tech/Sci/R&D Officer

President

Chief Tech/Sci/R&D Officer

Hospital/Nursing Management

Richard A. Moscicki

Henri A. Termeer

Mason W. Freeman

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

X4 PHARMACEUTICALS, INC. Biotechnology

Henri A. Termeer

Alison Lawton

Founder

Director/Board Member

University of Virginia Darden School of Business College/University

Henri A. Termeer

Helen Boudreau

Masters Business Admin

Masters Business Admin

University of California College/University

Mason W. Freeman

David Schaffer

Doctorate Degree

Corporate Officer/Principal

5am Partners Vi LLC

Andrew Schwab

Kush Parmar

Corporate Officer/Principal

Corporate Officer/Principal

AURINIA PHARMACEUTICALS INC. Biotechnology

Rashieda Gluck

Simrat Randhawa

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

ENLIVEN THERAPEUTICS, INC. Biotechnology

Andrew Schwab

Galya Blachman

Director/Board Member

General Counsel

PROQR THERAPEUTICS N.V. Pharmaceuticals: Major

Henri A. Termeer

Alison Lawton

Founder

Director/Board Member

University of Michigan College/University

Leonard Post

Liu Hui

Corporate Officer/Principal

Doctorate Degree

VERASTEM, INC. Biotechnology

Henri A. Termeer

Alison Lawton

Director/Board Member

Director/Board Member

Statistiche

Distribuzione geografica

Stati Uniti 39
Canada 3
Regno Unito 3
Germania 3
Paesi Bassi 3

Settori

Health Technology 25
Consumer Services 13
Commercial Services 5
Finance 5
Health Services 3

Posizioni

Director/Board Member 479
Corporate Officer/Principal 236
Independent Dir/Board Member 131
Chairman 93
Chief Executive Officer 81
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA